Patent ID: 7078566

Claim:
A pharmaceutical preparation for the treatment of tumor diseases, autoimmune diseases, cardiovascular diseases, infections, or viral diseases, comprising one or more salts of guanidine derivatives corresponding to the formula wherein X represents —CH 2 —NH—NH— or —CH═N—NH—, R represents a linear or branched C 1 –C 30 alkyl, C 3 –C 20 cycloalkyl, or tricyclodecyl residue, which can be substituted by one or more hydroxyl groups, C 1 –C 4 alkoxy groups, C 1 –C 4 alkyl groups and/or one or more halogen atoms or one or more amino groups, and Z represents O—CO—Y, O—S(O) 2 —Y, or O—P(O)(OH)—Y, wherein Y represents a linear or branched C 1 –C 12 alkyl, C 3 –C 8 cycloalkyl, benzyl, furyl or pyridyl residue, which can be substituted by one or more hydroxyl groups, carboxylic acid groups, C 1 –C 4 alkoxy groups, C 1 –C 4 alkyl groups and/or one or more halogen atoms or one or more amino groups.